Tag: post-marketing surveillance
Drug Safety Signals and Clinical Trials: How Hidden Risks Emerge After Approval
Drug safety signals emerge after approval when real-world use reveals risks missed in clinical trials. Learn how rare side effects are detected, why trials aren't enough, and what happens when a signal turns into a warning.
Read More